2023 -- H 5922
========
LC002079
========
S TATE OF RHODE IS LAND
IN GENERAL ASSEMBLY
JANUARY SESSION, A.D. 2023
____________
A N A C T
RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCE S ACT
Introduced By: Representatives Hull, Phillips, Diaz, Noret, DeSimone, Fogarty, Abney,
and Biah
Date Introduced: March 01, 2023
Referred To: House Judiciary
(Attorney General)
It is enacted by the General Assembly as follows:
SECTION 1. Section 21-28-2.08 of the General Laws in Chapter 21-28 entitled "Uniform 1
Controlled Substances Act" is hereby amended to read as follows: 2
21-28-2.08. Contents of schedules. 3
Schedules I through V shall consist of the drugs and other substances, by whatever official 4
name, common or usual name, chemical name, or brand name designated, listed in the 5
corresponding section, or designated by the director of the department of health pursuant to § 21-6
28-2.01. 7
Schedule I 8
(a) Schedule I shall consist of the drugs and other substances, by whatever official name, 9
common or usual name, chemical name, or brand name designated, listed in this section. 10
(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the 11
following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers 12
whenever the existence of the isomers, esters, ethers, and salts is possible within the specific 13
chemical designation: 14
(1) Acetylmethadol 15
(2) Allylprodine 16
(3) Alphacetylmethadol 17
(4) Alphameprodine 18
(5) Alphamethadol 19
LC002079 - Page 2 of 18
(6) Benzethidine 1
(7) Betacetylmethadol 2
(8) Betameprodine 3
(9) Betamethadol 4
(10) Betaprodine 5
(11) Clonitazene 6
(12) Dextromoramide 7
(13) Difenoxin 8
(14) Diampromide 9
(15) Diethylthiambutene 10
(16) Dimenoxadol 11
(17) Dimepheptanol 12
(18) Dimethylthiambutene 13
(19) Dioxaphetyl butyrate 14
(20) Dipipanone 15
(21) Ethylmethylthiambutene 16
(22) Etonitazene 17
(23) Extoxerdine 18
(24) Furethidine 19
(25) Hydroxypethidine 20
(26) Ketobemidone 21
(27) Levomoramide 22
(28) Levophenacylmorphan 23
(29) Morpheridine 24
(30) Noracymethadol 25
(31) Norlevorphanol 26
(32) Normethadone 27
(33) Norpipanone 28
(34) Phenadoxone 29
(35) Phenampromide 30
(36) Phenomorphan 31
(37) Phenoperidine 32
(38) Piritramide 33
(39) Proheptazine 34
LC002079 - Page 3 of 18
(40) Properidine 1
(41) Propiram 2
(42) Racemoramide 3
(43) Trimeperidone 4
(44) Tilidine 5
(45) Alpha-methylfentanyl 6
(46) Beta-hydroxy-3-methylfentanyl other names: 7
N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl]-Nphenylpropanamide 8
(47) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-9
phenylpropanamide) 10
(48) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, its optical, positional, and 11
geometric isomers, salts and salts of isomers (Other names: acetyl fentanyl) 12
(49) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenyl propionamide 13
(Other names: beta-hydroxythiofentanyl) 14
(50) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide (Other names: Butyryl fentanyl) 15
(51) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (Other names: Furanyl 16
fentanyl) 17
(52) 3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide (Other names: AH-18
7921) 19
(53) 3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (Other names: 20
U-47700) 21
(54) 3-Methylbutyrfentanyl (Other names: 3-MBF) 22
(55) 4-Fluorobutyrfentanyl (Other names: 4-FBF, p-FBF) 23
(56) 4-Phenylfentanyl 24
(57) 4-Methoxybutyrfentanyl (Other names: 4-MeO-BF) 25
(58) Acrylfentanyl (Other names: acryloyfentanyl) 26
(59) Lofentanyl 27
(60) N-Methylcarfentanyl 28
(61) Ocfentanyl (INN, A-3217) 29
(63) 4-methoxymethylfentanyl (Other names: R-30490) 30
(64) 1-cyclohexyl-4-(1,2 diphenylethyl)piperazine) (Other names: MT-45, IC-6) 31
(c)(b) Opium Derivatives. Unless specifically excepted or unless listed in another schedule, 32
any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the 33
existence of the salts, isomers, and salts of isomers is possible within the specific chemical 34
LC002079 - Page 4 of 18
designation: 1
(1) Acetorphine 2
(2) Acetyldihydrocodeine 3
(3) Benzylmorphine 4
(4) Codeine methylbromide 5
(5) Codeine-N-Oxide 6
(6) Cyprenorphine 7
(7) Desomorphine 8
(8) Dihydromorphine 9
(9) Etorphine (Except hydrochloride salt) 10
(10) Heroin 11
(11) Hydromorphinol 12
(12) Methyldesorphine 13
(13) Methylihydromorphine 14
(14) Morphine methylbromide 15
(15) Morphine methylsulfonate 16
(16) Morphine-N-Oxide 17
(17) Myrophine 18
(18) Nococodeine 19
(19) Nicomorphine 20
(20) Normorphine 21
(21) Pholcodine 22
(22) Thebacon 23
(23) Drotebanol 24
(d)(c) Hallucinogenic Substances. Unless specifically excepted or unless listed in another 25
schedule, any material, compound, mixture, or preparation that contains any quantity of the 26
following hallucinogenic substances, or that contains any of its salts, isomers, and salts of isomers 27
whenever the existence of the salts, isomers, and salts of isomers is possible within the specific 28
chemical designation (for purposes of this subsection only, the term “isomer” includes the optical, 29
position, and geometric isomers): 30
(1) 3, 4-methylenedioxy amphetamine 31
(2) 5-methoxy-3, 4-methylenedioxy amphetamine 32
(3) 3, 4, 5-trimethoxy amphetamine 33
(4) Bufotenine 34
LC002079 - Page 5 of 18
(5) Diethyltryptamine 1
(6) Dimethyltryptamine 2
(7) 4-methyl 2, 5-dimethoxyamphetamine 3
(8) Ibogaine 4
(9) Lysergic acid diethylamide 5
(10) Marihuana 6
(11) Mescaline 7
(12) Peyote. Meaning all parts of the plant presently classified botanically as Lophophora 8
Williamsii Lemair whether growing or not; the seeds of the plant; any extract from any part of the 9
plant; and any compound, manufacture, salt, derivative, mixture, or preparation of the plant, its 10
seeds or extracts. 11
(13) N-ethyl-3-piperidyl benzilate 12
(14) N-methyl-3-piperidyl benzilate 13
(15) Psilocybin 14
(16) Psilocyn 15
(17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the plant, 16
or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their 17
isomers with similar chemical structure and pharmacological activity such as the following: delta 18
1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans 19
tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and 20
their optical isomer. (Since nomenclature of these substances is not internationally standardized, 21
compounds of these structures, regardless of numerical designation of atomic positions covered). 22
(18) Thiophene analog of phencyclidine. 1-(1-(2 thienyl) cyclo-hexyl) pipiridine: 2-23
Thienyl analog of phencyclidine: TPCP 24
(19) 2,5 dimethoxyamphetamine 25
(20) 4 -bromo-2,5-dimethoxyamphetamine, 4 -bromo-2,5-dimethoxy-alpha-26
methylphenethyamine: 4-bromo-2,5-DMA 27
(21) 4 -methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine: 28
paramethoxyamphetamine: PMA 29
(22) Ethylamine analog of phencyclidine. N-ethyl-1-phenylcyclohexylamine, (1-30
phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine, PCE 31
(23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)-pyrrolidine PCPy, PHP 32
(24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-33
trimethyl-6H-dibenz o (b,d) pyran: Synhexyl. 34
LC002079 - Page 6 of 18
(25) Salvia Divinorum (Salvinorin A or Divinorin A), meaning any extract from any part 1
of the plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall 2
not mean the unaltered plant. 3
(26) Datura stamonium (jimsom weed or datura), meaning any extract from any part of the 4
plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall not mean 5
the unaltered plant. 6
(e)(d) Depressants. Unless specifically excepted or unless listed in another schedule, any 7
material, compound, mixture, or preparation that contains any quantity of the following substances 8
having a depressant effect on the central nervous system, including its salts, isomers, and salts of 9
isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the 10
specific chemical designation: 11
(1) Mecloqualone. 12
(2) Methaqualone. 13
(3) 3-methyl fentanyl (n-(3methyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide. 14
(4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional, and geometric 15
isomers, salts, and salts of isomers. 16
(5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts, and salts 17
of isomers. 18
(6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts, 19
and salts of isomers. 20
(7) N -(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-21
alphamethylfentanyl), its optical isomers, salts, and salts of isomers. 22
(8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha-23
methylthiofentanyl), its optical isomers, salts, and salts of isomers. 24
(9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers, 25
salts, and salts of isomers. 26
(10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta-27
hydroxyfentanyl), its optical isomers, salts, and salts of isomers. 28
(11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta-29
hydroxy-3-methylfentanyl), its optical and geometric isomers, salts, and salts of isomers. 30
(12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro-panamide (3-31
methylthiofentanyl), its optical and geometric isomers, salts, and salts of isomers. 32
(13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its 33
optical isomers, salts, and salts of isomers. 34
LC002079 - Page 7 of 18
(14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical 1
isomers, salts, and salts of isomers. 2
(15) N-[1-(2-phenylethyl)-4-piperidyl]-N-(4-fluorophenyl)-propanamid e (para-3
fluorofentanyl), its optical isomers, salts, and salts of isomers. 4
(16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or 5
geometric isomers, salts, and salts of isomers. 6
(17) Etizolam. 7
(18) Flubromazolam. 8
(f)(e) Stimulants. Unless specifically excepted or unless listed in another schedule, any 9
material, compound, mixture, or preparation that contains any quantity of the following substances 10
having a stimulant effect on the central nervous system, including its salts, isomers, and salts of 11
isomers: 12
(1) Fenethylline 13
(2) N-ethylamphetamine 14
(3) 4-methyl-N-methylcathinone (Other name: mephedrone) 15
(4) 3,4-methylenedioxy-N-methlycathinone (Other name: methylone) 16
(5) 3,4-methylenedioxypyrovalerone (Other name: MDPV) 17
(g) Any material, compound, mixture, or preparation that contains any quantity of the 18
following substances: 19
(1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) 20
(2) 5 -(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol 21
(cannabicyclohexanol and CP-47,497 c8 homologue) 22
(3) 1-Butyl-3-(1 naphthoyl)indole, (JWH-073) 23
(4) 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) 24
(5) 1-Pentyl-3-(1-napthoyl)indole, (JWH-018 and AM678) 25
(h)(g) Synthetic cannabinoids or piperazines. Unless specifically excepted, any chemical 26
compound which is not approved by the United States Food and Drug Administration or, if 27
approved, which is not dispensed or possessed in accordance with state and federal law, that 28
contains Benzylpiperazine (BZP); Trifluoromethylphenylpiperazine (TFMPP); 1,1-29
Dimethylheptyl-11-hydroxytetrahydrocannabinol (HU-210); 1-Butyl-3-(1-naphthoyl) indole; 1-30
Pentyl-3-(1-naphthoyl) indole; dexanabinol (HU-211); or any compound in the following structural 31
classes: 32
(1) Naphthoylindoles: Any compound containing a 3-(1-naphthoyl)indole structure with 33
substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, 34
LC002079 - Page 8 of 18
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 1
group, whether or not further substituted in the indole ring to any extent and whether or not 2
substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not 3
limited, to JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, and AM-4
2201; 5
(2) Phenylacetylindoles: Any compound containing a 3-phenylacetylindole structure with 6
substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, 7
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 8
group whether or not further substituted in the indole ring to any extent and whether or not 9
substituted in the phenyl ring to any extent. Examples of this structural class include, but are not 10
limited to, JWH-167, JWH-250, JWH-251, and RCS-8; 11
(3) Benzoylindoles: Any compound containing a 3-(benzoyl) indole structure with 12
substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, 13
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 14
group whether or not further substituted in the indole ring to any extent and whether or not 15
substituted in the phenyl ring to any extent. Examples of this structural class include, but are not 16
limited, to AM-630, AM-2233, AM-694, Pravadoline (WIN 48,098), and RCS-4; 17
(4) Cyclohexylphenols: Any compound containing a 2-(3-hydroxycyclohexyl)phenol 18
structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, 19
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 20
group whether or not substituted in the cyclohexyl ring to any extent. Examples of this structural 21
class include, but are not limited to, CP 47,497 and its C8 homologue (cannabicyclohexanol); 22
(5) Naphthylmethylindoles: Any compound containing a 1H-indol-3-yl-(1-naphthyl) 23
methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, 24
alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-25
morpholinyl)ethyl group whether or not further substituted in the indole ring to any extent and 26
whether or not substituted in the naphthyl ring to any extent. Examples of this structural class 27
include, but are not limited to, JWH-175, JWH-184, and JWH-185; 28
(6) Naphthoylpyrroles: Any compound containing a 3-(1-naphthoyl)pyrrole structure with 29
substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, 30
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 31
group whether or not further substituted in the pyrrole ring to any extent and whether or not 32
substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not 33
limited, to JWH-030, JWH-145, JWH-146, JWH-307, and JWH-368; 34
LC002079 - Page 9 of 18
(7) Naphthylmethylindenes: Any compound containing a 1-(1-naphthylmethyl)indene 1
structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, 2
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 3
group whether or not further substituted in the indene ring to any extent and whether or not 4
substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not 5
limited to, JWH-176; or 6
(8) Any other synthetic cannabinoid or piperazine which is not approved by the United 7
States Food and Drug Administration or, if approved, which is not dispensed or possessed in 8
accordance with state and federal law. 9
(i) Synthetic cathinones. Unless specifically excepted, any chemical compound which is 10
not approved by the United States Food and Drug Administration or, if approved, which is not 11
dispensed or possessed in accordance with state and federal law, not including bupropion, 12
structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, 13
naphthyl, or thiophene ring systems, whether or not the compound is further modified in one or 14
more of the following ways: 15
(1) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, 16
haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by 17
one or more other univalent substituents. Examples of this class include, but are not limited to, 3,4-18
Methylenedioxycathinone (bk-MDA); 19
(2) By substitution at the 3-position with an acyclic alkyl substituent. Examples of this 20
class include, but are not limited to, 2-methylamino-1-phenylbutan-1-one (buphedrone); 21
(3) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or 22
methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure. 23
Examples of this class include, but are not limited to, Dimethylcathinone, Ethcathinone, and α-24
Pyrrolidinopropiophenone (α-PPP); or 25
(4) Any other synthetic cathinone which is not approved by the United States Food and 26
Drug Administration or, if approved, is not dispensed or possessed in accordance with state or 27
federal law. Examples of this class include, but are not limited to, Ephylone and Pentylone. 28
Schedule II 29
(a) Schedule II shall consist of the drugs and other substances, by whatever official name, 30
common or usual name, chemical name, or brand name designated, listed in this section. 31
(b) Substances, vegetable origin, or chemical synthesis. Unless specifically excepted or 32
unless listed in another schedule, any of the following substances whether produced directly or 33
indirectly by extraction from substances of vegetable origin, or independently by means of 34
LC002079 - Page 10 of 18
chemical synthesis, or by a combination of extraction and chemical synthesis: 1
(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or 2
opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the 3
following: 4
(i) Raw opium 5
(ii) Opium extracts 6
(iii) Opium fluid extracts 7
(iv) Powdered opium 8
(v) Granulated opium 9
(vi) Tincture of opium 10
(vii) Etorphine hydrochloride 11
(viii) Codeine 12
(ix) Ethylmorphine 13
(x) Hydrocodone 14
(xi) Hydromorphone 15
(xii) Metopon 16
(xiii) Morphine 17
(xiv) Oxycodone 18
(xv) Oxymorphone 19
(xvi) Thebaine 20
(2) Any salt, compound, derivative, or preparation that is chemically equivalent or identical 21
with any of the substances referred to in subdivision (1) of this subsection, except that these 22
substances shall not include the isoquinoline alkaloids of opium. 23
(3) Opium poppy and poppy straw. 24
(4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any 25
salt, compound, derivative, or preparation that is chemically equivalent or identical with any of 26
these substances, except that the substances shall not include decocainized coca leaves or extraction 27
of coca leaves, which extractions do not contain cocaine or ecgonine. 28
(5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or powder 29
form that contains the phenanthrine alkaloids of the opium poppy). 30
(c)(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the 31
following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters, and ethers 32
whenever the existence of the isomers, esters, ethers, and salts is possible within the specific 33
chemical designation: 34
LC002079 - Page 11 of 18
(1) Alphaprodine 1
(2) Anileridine 2
(3) Bezitramide 3
(4) Dihydrocodeine 4
(5) Diphenoxylate 5
(6) Fentanyl 6
(7) Isomethadone 7
(8) Levomethorphan 8
(9) Levorphanol 9
(10) Metazocine 10
(11) Methadone 11
(12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane 12
(13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic 13
acid 14
(14) Pethidine 15
(15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine 16
(16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate 17
(17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid 18
(18) Phenaxocine 19
(19) Piminodine 20
(20) Racemethorphan 21
(21) Racemorphan 22
(22) Bulk Dextropropoxyphene (non-dosage forms) 23
(23) Suffentanil 24
(24) Alfentanil 25
(25) Levoalphacetylmethadol 26
(26) Carfentanil 27
(27) Remifentanil 28
(d)(c) Stimulants. Unless specifically excepted or unless listed in another schedule, any 29
material, compound, mixture, or preparation that contains any quantity of the following substances 30
having a stimulant effect on the central nervous system: 31
(1) Amphetamine, its salts, optical isomers, and salts of its optical isomers. 32
(2) Methamphetamine, its salts, and salts of its isomers. 33
(3) Phenmetrazine and its salts. 34
LC002079 - Page 12 of 18
(4) Methylphenidate. 1
(e)(d) Depressants. Unless specifically excepted or unless listed in another schedule, any 2
material, compound, mixture, or preparation that contains any quantity of the following substances 3
having a depressant effect on the central nervous system, including its salts, isomers, and salts of 4
isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the 5
specific chemical designation: 6
(1) Amobarbital 7
(2) Glutethimide 8
(3) Methyprylon 9
(4) Pentobarbital 10
(5) Phencyclidine 11
(6) Secobarbital 12
(7) Phencyclidine immediate precursors: 13
(i) 1-phencyclohexylamine 14
(ii) 1-piperidinocyclohexane-carbonitrile (PCC) 15
(8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some 16
other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone. 17
Schedule III 18
(a) Unless specifically excepted or unless listed in another schedule, any material, 19
compound, mixture, or preparation that contains any quantity of the following substances having a 20
depressant effect on the central nervous system: 21
(1) Any substance that contains any quantity of a derivative of barbituric acid or any salt 22
of a derivative of barbituric acid. 23
(2) Chlorhexadol 24
(3) Lysergic acid 25
(4) Lysergic acid amide 26
(5) Sulfondiethylmethane 27
(6) Sulfonethylmethane 28
(7) Sylfonmethane 29
(8) Any compound, mixture, or preparation containing amobarbital, secobarbital, 30
pentobarbital, or any salt of them and one or more other active medicinal ingredients that are not 31
listed in any schedule. 32
(9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or 33
any salt of any of these drugs and approved by the Food and Drug Administration for marketing 34
LC002079 - Page 13 of 18
only as a suppository. 1
(10) Ketamine, its salts, isomers, and salts of isomers. (Some other names for ketamine: 2
(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone). 3
(b) Unless specifically excepted or unless listed in another schedule, any material, 4
compound, mixture, or preparation containing limited quantities of any of the following narcotic 5
drugs, or any salts of them: 6
(1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred 7
milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal 8
or greater quantity of an isoquinoline alkaloid of opium. 9
(2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred 10
milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or 11
more active, nonnarcotic ingredients in recognized therapeutic amounts. 12
(3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one 13
hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with 14
a fourfold or greater quantity of an isoquinoline alkaloid of opium. 15
(4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one 16
hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with 17
one or more active nonnarcotic ingredients in recognized therapeutic amounts. 18
(5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one hundred 19
milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or 20
more active nonnarcotic ingredients in recognized therapeutic amounts. 21
(6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one hundred 22
milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with one or 23
more active nonnarcotic ingredients in recognized therapeutic amounts. 24
(7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred milliliters 25
(100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five milligrams (25 mgs.) 26
per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts. 27
(8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters (100 28
mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in 29
recognized therapeutic amounts. 30
(c) Stimulants. Unless specifically excepted or listed in another schedule, any material, 31
compound, mixture, or preparation that contains any quantity of the following substances having a 32
stimulant effect on the central nervous system, including its salts, isomers, and salts of the isomers 33
whenever the existence of the salts of isomers is possible within the specific chemical designation: 34
LC002079 - Page 14 of 18
(1) Benzphetamine 1
(2) Chlorphentermine 2
(3) Clortermine 3
(4) Mazindol 4
(5) Phendimetrazine 5
(d) Steroids and hormones. Anabolic steroids (AS) or human growth hormone (HGH), 6
excluding those compounds, mixtures, or preparations containing an anabolic steroid that because 7
of its concentration, preparation, mixture, or delivery system, has no significant potential for abuse, 8
as published in 21 C.F.R. § 1308.34, including, but not limited to, the following: 9
(1) Chorionic gonadotropin, except for veterinary use and when that use is approved by the 10
Food and Drug Administration. 11
(2) Clostebol 12
(3) Dehydrochlormethyltestosterone 13
(4) Ethylestrenol 14
(5) Fluoxymesterone 15
(6) Mesterolone 16
(7) Metenolone 17
(8) Methandienone 18
(9) Methandrostenolone 19
(10) Methyltestosterone 20
(11) Nandrolone decanoate 21
(12) Nandrolone phenpropionate 22
(13) Norethandrolone 23
(14) Oxandrolone 24
(15) Oxymesterone 25
(16) Oxymetholone 26
(17) Stanozolol 27
(18) Testosterone propionate 28
(19) Testosterone-like related compounds 29
(20) Human Growth Hormone (HGH) 30
(e) Hallucinogenic substances. 31
(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in U.S. 32
Food and Drug Administration-approved drug product. (Some other names for dronabinol: (6aR-33
trans)-6a, 7, 8, 10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or (-)-delta-34
LC002079 - Page 15 of 18
9(trans)-tetrahydrocannabinol.) 1
Schedule IV 2
(1) Barbital. 3
(2) Chloral betaine 4
(3) Chloral hydrate 5
(4) Ethchrovynol 6
(5) Ethinamate 7
(6) Methohexital 8
(7) Meprobamate 9
(8) Methylphenobarbital 10
(9) Paraldehyde 11
(10) Petrichloral 12
(11) Phenobarbital 13
(12) Fenfluramine 14
(13) Diethylpropion 15
(14) Phentermine 16
(15) Pemoline (including organometallic complexes and chelates thereof). 17
(16) Chlordiazepoxide 18
(17) Clonazepam 19
(18) Clorazepate 20
(19) Diazepam 21
(20) Flurazepam 22
(21) Mebutamate 23
(22) Oxazepam 24
(23) Unless specifically excepted or unless listed in another schedule, any material, 25
compound, mixture, or preparation that contains any quantity of the following substances, including 26
its salts: 27
Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propronox 28
ybutane). 29
(24) Prazepam 30
(25) Lorazepam 31
(26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25) 32
micrograms of atropine sulfate per dosage unit. 33
(27) Pentazocine 34
LC002079 - Page 16 of 18
(28) Pipradrol 1
(29) SPA (-)-1-dimethylamino-1, 2-diphenylethane 2
(30) Temazepam 3
(31) Halazepam 4
(32) Alprazolam 5
(33) Bromazepam 6
(34) Camazepam 7
(35) Clobazam 8
(36) Clotiazepam 9
(37) Cloxazolam 10
(38) Delorazepam 11
(39) Estazolam 12
(40) Ethyl Ioflazepate 13
(41) Fludizaepam 14
(42) Flunitrazepam 15
(43) Haloxazolam 16
(44) Ketazolam 17
(45) Loprazolam 18
(46) Lormetazepam 19
(47) Medazepam 20
(48) Nimetazepam 21
(49) Nitrazepam 22
(50) Nordiazepam 23
(51) Oxazolam 24
(52) Pinazepam 25
(53) Tetrazepam 26
(54) Mazindol 27
(55) Triazolam 28
(56) Midazolam 29
(57) Quazepam 30
(58) Butorphanol 31
(59) Sibutramine 32
(60) Tramadol 33
(61) Zolpidem 34
LC002079 - Page 17 of 18
Schedule V 1
(a) Any compound, mixture, or preparation containing any of the following limited 2
quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal 3
ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable 4
medicinal qualities other than those possessed by the narcotic drug alone: 5
(1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100 6
mls.) or per one hundred grams (100 gms.). 7
(2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100 milliliters 8
(100 mls.) or per one hundred grams (100 gms.). 9
(3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100 milliliters 10
(100 mls.) or per one hundred grams (100 gms.). 11
(4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less 12
than twenty-five (25) micrograms of atropine sulfate per dosage unit. 13
(5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred milliliters 14
(100 mls.) or per one hundred grams (100 gms.). 15
(b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than twenty-16
five (25) micrograms of atropine sulfate per dosage unit. 17
(c) Buprenorphine 18
(d) Unless specifically exempted or excluded or unless listed in another schedule, any 19
material, compound, mixture, or preparation that contains any quantity of the following substances 20
having a stimulant effect on the central nervous system, including its salts, isomers, and salts of 21
isomers: 22
(1) Propylhexedrine (except as benzedrex inhaler) 23
(2) Pyrovalerone. 24
(e) Xylazine HCL 25
SECTION 2. This act shall take effect upon passage. 26
========
LC002079
========
LC002079 - Page 18 of 18
EXPLANATION
BY THE LEGISLATIVE COUNCIL
OF
A N A C T
RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED S UBSTANCES ACT
***
This act would provide that Schedules I through V of the Uniform Controlled Substances 1
Act consist of drugs and other substances, by whatever official name, common or usual name, 2
chemical name or name designated by the director of the department of health, and would add 3
several new drugs to various schedules, including Etizolam, Flubromazolam, Tramadol, Zolpidem, 4
and Xylazine HCL. 5
This act would take effect upon passage. 6
========
LC002079
========